Literature DB >> 21817934

Intracochlear schwannomas confined to the otic capsule.

Zi Yang Jiang1, Joe Walter Kutz, Peter Sargent Roland, Brandon Isaacson.   

Abstract

OBJECTIVE: To determine the natural history and management for patients with intracochlear schwannomas. STUDY
DESIGN: Retrospective case series of intracochlear schwannomas confined to the otic capsule.
SETTING: Tertiary referral center. PATIENTS: Ten patients were found to have schwannomas limited to the cochlea from 1998 to 2009.
INTERVENTIONS: All subjects underwent at least 1 magnetic resonance imaging (MRI) study and had at least 1 audiogram. Two patients underwent a transotic excision for intractable symptoms. MAIN OUTCOME MEASURES: Presenting symptoms, initial and follow-up MRI findings, audiometric testing results, and need for surgical intervention were recorded for each subject.
RESULTS: Hearing loss was present in all 10 patients at their initial presentation. Tinnitus was present in 50% of patients, and vertigo was present in 30% of patients. No patient presented with aural fullness or facial weakness. The pattern of hearing loss seemed to correlate with the location of the lesion within the cochlea. Of the 9 patients that had follow-up MRIs, 3 patients showed tumor growth. Two of the 10 patients underwent surgical excision for intractable vertigo that resulted in resolution of symptoms.
CONCLUSION: Hearing loss is the most common finding in patients with intracochlear schwannomas, followed by tinnitus and vertigo. If the patient does not have symptoms of intractable vertigo, observation with serial MRI scans is indicated. Surgical excision should be reserved for patients with intractable vertigo or with significant tumor growth.

Entities:  

Mesh:

Year:  2011        PMID: 21817934     DOI: 10.1097/MAO.0b013e31822a20ea

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  8 in total

Review 1.  Meta-analysis on the clinical outcomes in patients with intralabyrinthine schwannomas: conservative management vs. microsurgery.

Authors:  Émilie Gosselin; Anastasios Maniakas; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

Review 2.  Secondary Endolymphatic Hydrops.

Authors:  Ashley P O'Connell Ferster; Sebahattin Cureoglu; Nevra Keskin; Michael M Paparella; Huseyin Isildak
Journal:  Otol Neurotol       Date:  2017-06       Impact factor: 2.311

3.  Intracochlear schwannoma: diagnosis and management.

Authors:  Aline Gomes Bittencourt; Ricardo Dourado Alves; Liliane Satomi Ikari; Patrick Rademaker Burke; Eloisa Maria Santiago Gebrim; Ricardo Ferreira Bento
Journal:  Int Arch Otorhinolaryngol       Date:  2014-01-07

4.  Minimally Invasive Surgery for Intracochlear Schwannoma Removal and Simultaneous Cochlear Implantation.

Authors:  Ricardo Ferreira Bento; Eloisa Maria Mello Santiago Gebrim; Ana Tereza de Matos Magalhães; Larissa Vilela Pereira; Anna Carolina de Oliveira Fonseca
Journal:  Int Arch Otorhinolaryngol       Date:  2016-04-07

5.  Transmeatal microsurgery for intralabyrinthine and intrameatal schwannomas: a reappraisal.

Authors:  Antonio Mazzoni; Elisabetta Zanoletti; Diego Cazzador; Leonardo Calvanese; Domenico d'Avella; Alessandro Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-10       Impact factor: 2.124

6.  Minimally invasive surgical removal of an intracochlear schwannoma causing an intractable paroxysmal positional vertigo.

Authors:  B Sergi; E De Corso; D Lucidi; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-10       Impact factor: 2.124

7.  Different clinical presentation of intralabyrinthine schwannomas - a systematic review.

Authors:  Thaís Gomes Abrahão Elias; Adriana Perez Neto; Ana Tereza Silveira Zica; Marcos Luiz Antunes; Norma de Oliveira Penido
Journal:  Braz J Otorhinolaryngol       Date:  2018-06-21

Review 8.  Transmeatal microsurgery for intralabyrinthine and intrameatal schwannomas: literature review.

Authors:  Daniele Marchioni; Flavia Di Maro; Livio Presutti
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-06       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.